Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2026-01-02 @ 3:39 AM
Study NCT ID:
NCT01002703
Status:
UNKNOWN
Last Update Posted:
2011-08-12
First Post:
2009-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
University of Leipzig
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RBP-01/08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Prof. Dr. med. Dr. h.c. Dietger Niederwieser
Old Organization:
University of Leipzig